Proprotein convertases (PCs) are highly specific proteases required for the proteolytic modification of many secreted proteins. An unbalanced activity of these enzymes is connected to pathologies like cancer, atherosclerosis, hypercholesterolaemia, and infectious diseases. Novel protein crystallographic structures of the prototypical PC family member furin in different functional states were determined to 1.8-2.0 Å. These, together with biochemical data and modeling by molecular dynamics calculations, suggest essential elements underlying its unusually high substrate specificity. Furin shows a complex activation mechanism and exists in at least four defined states: (i) the "off state," incompatible with substrate binding as seen in the unliganded enzyme; (ii) the active "on state" seen in inhibitor-bound furin; and the respective (iii) calcium-free and (iv) calcium-bound forms. The transition from the off to the on state is triggered by ligand binding at subsites S1 to S4 and appears to underlie the preferential recognition of the four-residue sequence motif of furin. The molecular dynamics simulations of the four structural states reflect the experimental observations in general and provide approximations of the respective stabilities. Ligation by calcium at the PC-specific binding site II influences the active-site geometry and determines the rotamer state of the oxyanion holeforming Asn295, and thus adds a second level of the activity modulation of furin. The described crystal forms and the observations of different defined functional states may foster the development of new tools and strategies for pharmacological intervention targeting furin.
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serine-protease | activation | specificity | conformational transition F urin belongs to the family of highly specific, calcium-dependent proprotein/prohormone convertases (PCs) (1) , endoproteinases that feature a catalytic domain of homology to subtilisin and activate a large number of secreted proteins by limited proteolysis. Furin is a type I transmembrane serine-protease that is ubiquitously expressed and cycles from the trans-Golgi network to the cell membrane, as well as through the endosomal system. In mammals, the PC family embraces seven members that cleave after multiple basic residues (furin, PC1, PC2, PC4, PACE4, PC5/6, and PC7) and at the general cleavage site (R/K)X n (R/K)↓ (where "↓" represents the scissile peptide bond), with furin preferentially recognizing the motif R-X-K/R-R↓ (2). This highly sequence-specific cleavage is essential for the activation of numerous PC substrates (2) . The PCs are also involved in a large number of pathologies, including bacterial and viral infections, as well as cancer and metastasis. Therefore, these enzymes are intensely investigated as drug targets (3), using for example, peptide-derived compounds (4) (5) (6) (7) (8) (9) , nonpeptidic small molecule compounds (10, 11) , and protein-based inhibitors (12) (13) (14) (15) .
Different crystal structures of the inhibitor-bound murine (16) and human (6, 17) enzyme, together with structural studies of the yeast homolog Kex2p (18, 19) and modeling approaches (9, 20), gave hints of how substrates and substrate-derived inhibitors bind with high specificity to furin and to the PCs, but suffer from the lack of structural information of the unliganded enzyme. The commonly accepted notion is that the PCs bind their cognate substrates via recognition at several subsites, typically involving multiple tight contacts and hydrogen bonds. Catalytic efficiency, however, in addition to strong and fast binding of substrate, requires rapid chemical transformation and fast release of product.
The chemical reaction catalyzed by furin and other proteasesthe hydrolysis of the scissile peptide bond-often involves limited structural changes of the active site residues, which are unlikely to perturb remote substrate-binding subsites of the enzyme. Furin has an extended substrate-binding area where typically all specificity-determining residues are located N-terminal to the scissile peptide bond, suggesting that the C-terminal segment is more loosely bound and may dissociate readily after hydrolysis. Potent
Significance
The prototypical proprotein convertase furin proteolytically activates many precursor proteins and is essential for cellular homeostasis of the cell. Furin and other proprotein convertase are also associated with a number of diseases, including cancer, atherosclerosis, hypercholesterolaemia, and infectious diseases. A hallmark of furin and its physiologic function is its stringent specificity for polybasic substrates. Here we describe several structural states of the protein by X-ray crystallography and further characterize them by molecular dynamics simulations. The transition between these conformers is triggered by substrate binding and calcium ligation, respectively, and helps explain the stringent specificity of furin and its functional features. These studies may pave the way for novel strategies of structure-guided inhibitor development. noncovalent inhibitors are characterized by very slow off-rates, a feature that may apply to very tight binding substrates that are poorly cleaved as well, and can thus act as efficient inhibitors as those, for example, shown in other protease families for the slowly hydrolyzed dipeptidyl peptidase IV substrate diprotin A (21) .
The high substrate selectivity and enzymatic activity of furin, and its strict Ca 2+ dependence, demand a structure-based explanation. Although Ca 2+ is not involved in the catalytic cycle per se, all PCs require calcium for their enzymatic activity (17, 22, 23) .
One more distinctive feature of furin in the protease family is its very limited reactivity toward typical covalent inhibitors of serine proteases, like diisopropylfluorphosphat (DFP) and phenylmethylsulfonylfluorid (PMSF). Interestingly, the spatial restrictions at and around the catalytic serine residue 368 of furin are structurally reminiscent of typical trypsin-like proteases. This similarity is especially evident for the deep S1 pocket selecting for basic amino acid side chains at P1, the β-strand of the enzyme (Ser253-Gly255 in furin vs. Ser214-Gly216 in trypsin), displaying antiparallel β-sheet-like contacts with a peptidic substrate and a typical hydrophobic tryptophane (Trp254 in furin vs. Trp215 in trypsin) in its center. Therefore, one would expect a similar reactivity of furin against nonselective, covalent inhibitors that do not specifically interact with the different specificity pockets, but probe the nucleophilic catalytic site serine residue; however, this has not been observed. Furin is also completely inert against typical monobasic trypsin-substrates (our own observations and those, for example, in refs. 22 and 24) . This is observed even though (i) the P1 requirements of the two enzymes are comparable, (ii) furin accepts different residues at its S2-pocket, and (iii) its S3-pocket is not very specific.
To address the above questions and to find out how the high negative-charge density within the active site cleft of furin is stabilized in its ligand-free state, we have studied the structure of the unliganded enzyme as well as of different Ca 2+ and inhibitor-bound forms by X-ray crystallography at high resolution. Comparison of the different crystal structures together with solution studies and molecular dynamics (MD) simulations give hints of the enzymatic mechanism and the unique features of this central regulatory endoproteinase.
Results
Inhibitor-Induced Structural Changes of the Active-Site Cleft. Human furin was crystallized in its unliganded state, its structure solved by molecular replacement (MR), and refined up to 1.8-Å resolution at high quality ( Fig. 1A and Table S1 ). Structure alignments of unliganded furin with the inhibitor-bound human and mouse furin structures demonstrated high overall similarity (Cα-rmsd of 0.22 Å and 0.28 Å, respectively). A close inspection of the active-site residues and the substrate-binding cleft, however, revealed substantial differences.
To directly investigate structural changes occurring upon substrate binding in identical crystal forms, we soaked the unliganded crystals with the substrate analogous, noncovalent inhibitor m-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(4-amidomethyl)-benzamidine (MI-52, #26 in ref. 4) . The active-site cleft of furin is oriented toward large solvent channels in these crystals, enabling the binding of large peptidic compounds to the protease unperturbed by crystal packing. The crystal structure was refined at a resolution of 2.0 Å (Table S1 ). A residue-wise comparison of unliganded and inhibitor-bound forms revealed a number of significant structural changes (Fig. S1A) . Hotspots of conformational changes include the catalytic residues His194, Ser368, Asn295 of the oxyanion hole, the sodium binding site (Thr309 and Ser316), and residues in direct contact with the inhibitor peptide (e.g., the region Ser253-Pro256, the alignment template). Mapping of the Cα displacement to the surface of the structure induced by inhibitor binding revealed a concerted local rearrangement at the substrate-binding cleft (Fig. 1B and Fig. S1B ). These displacements propagate with diminishing amplitude to the core of the protease (Fig. S1C) . The catalytic residues and the alignment template are well defined in the electron-density maps ( Fig. S2 A and B) and characterized by low flexibility.
A structural comparison of the substrate-binding region indeed revealed two distinct conformational states for furin ( Fig. 2A and Fig. S3A ). In contrast, the homologous unspecific protease subtilisin showed a high overall structural similarity (Cα rmsd of 0.24 Å) of the unliganded structure [PDB ID code 3UNX (25) A principal component analysis (PCA) was carried out to gain further insight into the structural modifications induced by inhibitor binding and their relationship with furin's homologous proteins. To allow a direct comparison between furin and the closely related protease subtilisin Carlsberg, a common core of 191 residues was selected to perform the PCA on their Cα atoms. Projecting the crystallographic structures on the first principal component, which captures more than 80% of the variance, shows a clear separation among the furin structures with and without ligand-bound conformations (Fig.  3A) , but not among the subtilisin Carlsberg structures, where both unliganded and inhibitor-bound conformations exhibit closer similarity to the furin inhibitor-bound structures. These observations prompted us to consider the first principal component as an appropriate metric to monitor the unliganded and inhibitor-bound states. A detailed inspection revealed that the conformation of residues proximal to the alignment template and the active site of subtilisin and furin are similar in the ligand-bound state (overall Cα rmsd of 0.38 Å) ( Fig. 2C and Fig. S3C ): specifically, the rotamers of Ser221 of subtilisin and Ser368 of furin, respectively. Conversely, the unliganded conformations of both enzymes differ and reflect the structural transition in furin absent in subtilisin. Interestingly, the PCA covariance matrix unveils a concerted movement between the alignment template (Ser253-Pro256), residues neighboring the sodium binding site (314-317), and the oxyanion hole (290-297 and 365-369) again.
The unliganded structure of furin has the side chain of Ser368 rotated 180°away from the S1 pocket and the scissile peptide bond, as defined in the dec-RVKR-cmk complex structure (16) , altering the interaction geometry of the catalytic triad and disrupting the essential hydrogen bond to His194. However, a nucleophilic attack at the scissile peptide bond requires a conformation, as observed in the inhibitor-bound structure. The rotamer of Ser368 as observed in the unliganded structure can thus not enable substrate processing. Interestingly, the rotameric state of Asn295 in the unliganded and the ligand-bound forms is largely identical as long as the Ca 2+ -(II) site is occupied (see Calcium-Dependent Activity Regulation of Furin, below).
The loss of the hydrogen bond between Ser253-OH and the carbonyl-O of Ser368 appears to facilitate the reorientation of Ser368 in unliganded furin ( Fig. 2A and Fig. S3A ). In addition, binding of peptide chains to the active-site cleft of furin requires a specific orientation of the alignment template, enabling characteristic backbone interactions and a P1-side-chain recognition. These interactions are incompatible with the unliganded structure ( Fig. 2A and Fig. S3A ). Furthermore, steric clashes between ligand and the enzyme would occur, especially at P1 and P4. In conclusion, the catalytic residues and the substrate-binding region adopt an inactive conformation in the unliganded furin structure, representing an "off" state. By binding of the substrate-analog inhibitor MI-52, the enzyme switches to a catalytically active "on" state.
MD Calculations Show Switching Between the On and Off States.
Next we assessed the stability of the unliganded and inhibitorbound conformations by performing MD simulations. For this purpose, furin and subtilisin were simulated in three different conditions: (i) an unliganded state, (ii) an inhibitor-bound state, and (iii) an inhibitor-removed state (protein in its inhibitor-bound conformation with the inhibitor molecule deleted). Histograms collected from projecting MD trajectories on the first principal component show that for furin, the inhibitor-removed state drifts away from its initial inhibitor-bound conformation. It relaxes toward a conformation that resembles the crystallographic unliganded conformation and approaches the relaxation state reached by simulations of furin's unliganded state (Fig. 3B) . In contrast the inhibitor-bound simulations show that the furin-MI-52 complex is highly stable, sampling conformations around its crystallographic pose. Notably, furin simulations in its unliganded state eventually visit the ligandbound conformation, thereby suggesting that the latter is a thermally accessible state. In subtilisin, all three systems retain their crystallographic conformations and sample inhibitor-bound-like structures (Figs. 2B and 3B and Fig. S3B ). These results suggest that in furin, but not in subtilisin, a fraction of the ligand binding energy is spent in transforming the enzyme from an off state to an on state.
Prompted by these observations, we reanalyzed the melting temperatures (T m ) of furin-inhibitor complexes and their dependence on the K i -values (6) . In a semi-logarithmic representation of the data, an apparent linear relationship between pK i (range 6.4-11.3) and T m can be found. Interestingly, by extrapolation to pK i -values < 6, T m falls below the value observed for unliganded furin. We reason that the dependence of melting temperature and stability on ligand affinity rests on two opposing factors: a gain in bonding interactions and energy with increasing affinity and a loss by the conformational switch with all ligands, such that the latter prevails with weakly binding ligands.
Specific Entities Define the Structural Difference Between the Two
Conformational States. Comparisons of the unliganded and inhibitorbound crystallographic structures provide insight regarding to the key structural features that characterize the on state. Different alignment template configurations allow hydrogen bond formation between Ser253γOH and the carbonyl oxygen of Ser368 in the on state, whereas this interaction is absent in the off state. This interaction prompts a Ser368 side-chain rotation of 180°away from the S1 pocket, thereby altering the interaction geometry of the catalytic triad. The MD simulations support this mechanism because, in the furin-inhibitor complex, the Ser253γOH-Ser368O hydrogen bond is observed 88% of the time, considering all repetitions (SI Materials and Methods), as a part of a dynamic process, and the rotameric state of Ser368 is stable in the experimentally observed conformation (Fig.  S4A) . In contrast, in the furin unliganded system this hydrogen bond is practically never observed (1% of the time) and the distribution of Ser368 χ-angle is bimodal, suggesting a dynamic equilibrium between the two orientations. Interestingly, the dynamic behavior of Thr367 appears to be also related to the on and off states. The Thr367 χ1 dihedral angle (Fig. S4B ) displays a single orientation in the liganded state corresponding to the crystal structure, whereas the unliganded form shows, as for Ser368, two stable orientations. However, only one of these orientations corresponds to that observed in the crystals. The MD data suggest that Thr367 χ1 also samples an orientation where its hydroxyl group approaches the S1 pocket and the Asn295's side chain.
Conformational changes are also transduced to the single sodium binding site of the protease (Fig. S5 ). In the unliganded structure the sodium ion is coordinated by the carbonyl oxygens of Thr309, Ser311, and Thr314, the hydroxyls of Thr314 and Ser316, as well as one water molecule, in the preferred octahedral coordination. Upon inhibitor binding, the coordination changes to a tetragonal-pyramidal geometry that is less frequently observed. The side-chain rotations of Ser316 and Thr309 result in breakage of the coordinative bond to the sodium ion and loss of the hydrogen bond between these residues, indicating a switch from a lower (unliganded form) to a higher (liganded form) energy state. Accordingly, in the MD simulations of the unliganded system the rotameric state of Ser316 is highly stable and the Ser316γOH-Thr309γOH interaction is relatively well conserved, being present 50% time in a dynamic fashion considering all repetitions.
Reaction of Furin with Nonspecific Inhibitors. Previous studies had demonstrated a lack of reactivity of furin for nonspecific covalent serine protease inhibitors (22) . We have reanalyzed here the inihibitory potency of DFP, 4-(2-aminoethyl)benzensulfonylfluorid (AEBSF), and PMSF. All three inhibitors readily inhibited the activity of the two prototypical serine proteases, trypsin and subtilisin, to below 3% of their original activity, but did not significantly affect the activity of human furin (SI Materials and Methods). As modeling excluded steric reasons, the failure of these inhibitors to bind may reflect the electronic properties and activation state of furin's active site, and thus represent an electrophilic probe and measure for the reactivity of the protease.
Calcium-Dependent Activity Regulation of Furin. Previous studies have shown that the activity of furin is dependent on the presence of calcium (22) . To investigate its role in activity regulation and substrate binding, we soaked unliganded furin crystals with EDTA, and analyzed and refined the structure to 2.0-Å resolution (Table S1 ). To our surprise, only the Ca 2+ -(II) and Ca 2+ -(III) ions (Fig. 1A) were removed by addition of the strong calcium chelator, suggesting different affinities of the three calcium binding sites. We further analyzed their anomalous diffraction at defined concentrations of Ca 2+ (Table S2) , finding decreasing affinities in the order Ca (Fig. S6 A-D) . A structural comparison of unliganded furin crystals soaked with either EDTA or grown in the presence of 1 mM Ca 2+ revealed almost an identical result in the PCA (Fig. 3A) and in the Cα overlay (rmsd 0.09 Å) (Fig. S7) . In addition, the distribution of B-factors of surface-exposed residues is highly similar. However, a detailed inspection of the active-site residues revealed differences at the Ca 2+ -(II) binding site. Although the calcium ligands Asp258, Asp301, and Glu331 undergo only slight changes upon removal of Ca 2+ -(II), the side chain of Asn295 displays a different rotamer and loses its role as central component of the oxyanion hole, where it forms a hydrogen bond to and thus polarizes the carbonyl oxygen of the scissile peptide (Fig. S6 E and  F) . In the Ca 2+ -(II)-free state the side chain of Asp258 may be protonated. It moves slightly toward the position of the previously bound calcium ion such that it now forms a hydrogen bond with the flipped side-chain amide of Asn295. Charging of the Ca 2+ site pushes Asp258 away and causes a reorientation of the Asn295 side chain to the catalytically competent conformation. Distortion of the oxyanion hole explains the calcium requirement for catalysis. EDTA-soaked crystals were also subjected to a second soaking step with MI-52 to study the impact of ligand binding (Table S1) . Interestingly, the observed changes triggered by the inhibitor are nearly identical to those observed in the Ca 2+ -(II)-bound forms (Fig. S6E) . The conformation of the Ca 2+ -(III) ligands are identical in presence and absence of Ca 2+ (Fig. S6D) . A series of five independent MD simulations was performed on the EDTA-soaked unliganded furin structure to evaluate the consequences of the empty Ca 2+ -(II) site on dynamics. These simulations were carried out considering two Asp258 protonation states. Interestingly, in simulations where Asp258 is protonated, its sidechain orientation corresponds to that observed in the crystal, but showed a second conformation in its charged state (Fig. S4C) . The experimentally observed orientation of the Asn295 side chain in Ca 2+ -(II)-free unliganded furin crystals was only seen as a minor species in MD; it mainly sampled conformations more similar to those observed in the Ca 2+ -(II)-bound state (Fig. S4D) . Nevertheless, prominent differences were observed in Gly255 and in the catalytic triad geometry. The empty ion pocket allows more rotational freedom to Gly255's ψ angle (Fig. S4E) . Because Gly255 is a key element of the alignment template, its structural alteration impairs substrate recognition. Although in this case the MD simulations and the crystallographic observations do not reinforce each other in detail, they both suggest that Ca 2+ -(II) stabilizes substrate binding and processing.
Discussion
The herein described crystals of unliganded furin allowed us to investigate conformational rearrangements triggered by substrate and calcium binding to PCs. These studies revealed two activityswitches affecting the functionality of the active site dependent upon substrate and calcium, respectively. Comparing the structures of unliganded and inhibitor-bound furin, we observe a significant structural rearrangement of the substrate-binding cleft without alteration of the global fold of the protease, which provides a structural framework and should be highly conserved in orthologs of this enzyme as well (6, 16, 17) . The active-site cleft shuttles between two structurally well-defined states of the enzyme, the inactive off and the active on states.
Furin and the bacterial subtilisin show highly conserved catalytic domains in their inhibitor-bound states, but differ significantly in their unliganded forms. In addition, inhibitorfree subtilisin displays a relatively high structural flexibility at the S1 and S4 pockets (27) , indicating plasticity and hence facilitating the binding of different sequence motives. In furin, the substrate-binding area is characterized by low B-factors, indicating a rigid framework in both the unliganded and the ligand-bound forms. Ligand binding and rearrangements of the S1 and S4 sites and the main chain are cooperatively coupled with the active-site residues, in particular Ser368. The observed inactivity of furin with nonspecific covalent inhibitors that probe the nucleophilicity of the active site Ser368 but lack S1 to S4 substituents reflects this cooperativity.
We suppose that the switch between two rigid conformations requires precise bonding interactions and restricts substrate binding to a well-defined sequence motif. Exceptional substrate specificity is a hallmark of furin and other PCs, and hence a fundamental requirement of a functional secretory system and for cellular homeostasis (2) .
The MD simulations demonstrate relaxation of the inhibitorbound on state to the unliganded conformation following ligand dissociation (Fig. 3B) . This finding shows that furin can switch between these two states and that the active on state of furin is less stable and requires the presence of a bound substrate or substrate-like inhibitor. This finding is in line with our extrapolation of the T m to weak K i -values that also suggests a lower structural stability of an inhibitor-free on state of furin. The MD simulations indicate that the on state is already visited in the ligand-free condition, thus suggesting that the substrate may bind directly to this state without energy expenditure (Fig. 3B) . However, in such a scenario a better performance would be expected from the nonspecific covalent inhibitors of the serine protease family (22) (SI Materials and Methods). This evidence argues in favor of a mechanism, where the energy cost of the activation and stabilization of the protease in its on state is paid by ligand binding. Further support to this mechanism comes from the observed change in the coordination sphere of the sodium binding site in furin that is linked to inhibitor binding. The previously noted rather atypically bent or kinked conformation of the Arg-side chain at P4 (16, 20) , which also corresponds to an energetically unfavorable yet well-defined conformation, may also consume some of the binding energy. In addition, a general stabilization of furin by inhibitor binding was demonstrated previously (6) and is recapitulated in the MD simulations, showing a substantially narrower distribution of conformers of the complex compared with the unliganded forms (Fig. 3B) .
These considerations are relevant for the catalytic properties of furin. The requirement of energy to convert the protease from the off to the on state affects substrate specificity, because only ligands with sufficient binding energy may activate the enzyme. It also nicely explains the efficient cleavage of Arg-X-X-Arg↓ substrates that occupy the S1 and S4 sites. These are highly preferred to X-X-(Lys/Arg)-Arg↓ substrates. Monobasic peptides are even completely inert against proteolysis by furin (24, 28) . A substrate-induced conformational shift might also influence the catalytic efficacy of the protease. Extensive proteasesubstrate interactions as described for furin usually result in large binding energies, and hence slow off-kinetics of the formed products and, in essence, in slow turnover of the substrate. A structural rearrangement could absorb some of the energy of substrate binding; it might reduce the net binding energy and thus allow for the observed fast kinetics of the PCs (28) that is comparable, for example, to the much less-specific subtilisin.
Two principal mechanisms may govern the transition from the off to the on state of furin: that is, induced fit triggered by ligand binding or conformational selection (Fig. 4) . In the absence of experimental kinetic data, the MD simulations may provide a hint for the latter, as the ligand-removed form relaxes toward the unliganded structure within the first 20 ns and the unliganded form shows a relatively broad distribution of conformers (Fig. 3B) . In addition, the χ1 angle histograms of the amino acid side chains with alternative torsions in unliganded and liganded forms show mostly bimodal distributions in the former, in accord with conformational equilibria (Fig. S4) .
Ligand-induced structural changes in proteases have been found and intensely studied by structural and MD studies in the proteasome, where only precisely defined enzyme main-chain peptidic ligand interactions induce opening and closing of the substratebinding cleft, whereas other ligands do not have this effect. In addition, a variant of the proteasome, the immune proteasome, does not shuttle between different conformers and remains in the enzymatically competent conformation in the ligand-free form. This finding was interpreted as an important factor, contributing to the superior activity of the immune proteasome (29) .
Another example of a protease shown to switch the conformation upon interaction with substrate (or inhibitor) is the αI-tryptase variant rHTαG I , which exhibits equilibria between the two states (30) . Comparing furin to the 3C protease family, which embraces cysteine-type proteases with trypsin-like fold-including for example, tobacco etch virus protease or human rhinovirus 14 3C protease [HRV14, PreScission protease (31)]-shows that the conformation of the catalytic residues is here unaffected by substrate binding, pointing to a different mechanism to achieve the required high specificity. Additional reports on substrate-induced activation of proteases regard, for example, the caspase family (32, 33) , where a more complex mechanism (also depending on dimerization, proteolytic cleavage, and conformational change) regulates their cleavage activity, and the oligopeptidase family (34) , where [in essence similar to furin's regulation by Ca 2+ -(II)] structural alterations in the vicinity of the oxyanion hole of the protease are described.
We also studied the three binding sites of calcium observed for human furin (17 (22) .
The dynamic data of the MD simulations suggest, however, that with an empty Ca 2+ -(II) pocket substrate binding has to pay an extra energetic penalty because of the destabilization of the Gly255 backbone and the side chain of Asp258 (Fig. S4 C-E) . Interestingly, when Asp258 was protonated, together with an empty Ca 2+ -(II) pocket, its crystallographic pose was retained and the effect on Gly255 disappeared (Fig. S4 C-E) . Here the MD simulations do not reflect the crystallographic data in detail, demonstrating only a partial reorientation of the Asn295 side chain in the Ca 2+ -(II)-free form (Figs. S3 and S4D) . A closer inspection of furin and subtilisin offers a possible explanation for this apparent failure. In subtilisin Asn155's orientation is reinforced by a hydrogen bond with Thr220Oγ, equivalent to Thr367 in furin. In the subtilisin simulations, the Asn155Nδ-Thr220Oγ hydrogen bond was indeed observed over 95% of the whole simulated time.
In accord with subtilisin and the murine furin structure [PDB ID code 1P8J (16) ], crystallized in the presence of a covalent inhibitor, the Asn295 orientation is reinforced by establishing a hydrogen bond with Thr367. In both proteins, murine furin and subtilisin, the Asn295-Thr367 interaction is achieved by positioning the Thr367 side chain with a χ1 dihedral angle at ∼60°. Strikingly, this apparently crucial orientation is very well observed in the human furin simulations (Fig. S4B) . The failure to observe the Asn295 conformation in our simulations may be because of the fact that Thr367 was not initially oriented to support this interaction. Remarkably, further stabilization of Asn295's crystallographic pose was achieved in MD simulations of the furin unliganded structure, when the interaction between Thr367 and Asn295 was artificially set as a starting condition (Fig. S4D) .
The activity of furin seems to be controlled by two intertwined mechanisms, including (i) a calcium-triggered switch mediated by the Ca 2+ -II site and (ii) a conformational on/off switch, both connected to substrate specificity and catalytic efficiency. This rather elaborate activation mode is probably essential for the unusually high substrate selectivity seen of furin and the other highly homologous PC-family members (20) . The described twofold activation mechanism and the underlying structural basis offer opportunities for activity modulation of either individual PCs or multiple family members.
Materials and Methods
Expression, Crystallization, and Structure Determination. Details regarding the plasmids, the expression system, purification procedure, and functional analysis used for human furin were described previously (17) and are also given in SI Materials and Methods. Crystals of human furin were grown in sitting drops mixing equal volumes of the protein solution (∼9 mg/mL) and crystallization solution [100 mM Mes, 200 mM K/NaH 2 PO 4 , pH 5.5-6.0, 3-4 M NaCl, and 3% (vol/vol) DMSO]. The reservoir contained 3-4 M NaCl. For inhibitor binding studies, the crystals were soaked with MI-52 (4) and for the calcium-studies the crystals were soaked with EDTA and Ca 2+ . Diffraction data were collected at beamline 14.1 of the Helmholtz-Zentrum Berlin (35) , processed with XDS (36) and programs of the CCP4-suite (37) . Phasing was performed by MR using the human furin-inhibitor complex structure [PDB ID code 4RYD (6)] and PHASER (38) ; the model was built in COOT (39) and refined in PHENIX (40) . Structural alignments and graphics were prepared in PYMOL (www.pymol.org) (see SI Materials and Methods for further details).
Principal Component Analysis. A PCA was carried out on Furin's crystallographic structures (SI Materials and Methods).
MD Simulations. The MD simulations were performed using the GROMACS (41) (v5.0.3) molecular simulation package (see SI Materials and Methods for further details).
Note Added
During preparation and revision of our report, PDB ID structure 4Z2A (10.2210/pdb4z2a/pdb; www.rcsb.org/pdb/explore. do?structureId=4Z2A) became available, which also shows a structure of human unliganded furin.
